Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Anavex Life Sciences Corp.
organization2 mentionslast seen Oct 20, 2026
Clinical-stage biopharmaceutical company developing treatments for central nervous system diseases.
Relationships 4
Relationship
Anavex Life Sciences Corp.developsblarcamesine
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 20, 2026ANAVEX LIFE SCIENCES CORP. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Anavex Life Sciences Corp. ("Anavex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative treatments for central nervous system diseases with significant unmet medical needs, today provided a corporate update highlighting progress across its three core indications for blarcamesine (ANAVEX 2-73)
- filingSEC EDGAROct 15, 2026ANAVEX LIFE SCIENCES CORP. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Anavex Life Sciences Corp. (the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative treatments